SUPERIOR ENDOSCOPIC AND DEEP REMISSION OUTCOMES IN ADULTS WITH MODERATE TO SEVERE CROHN'S DISEASE MANAGED WITH TREAT TO TARGET APPROACH VERSUS CLINICAL SYMPTOMS: DATA FROM CALM

(1) Icahn School of Medicine at Mount Sinai,New York,United States of America

(2) University of Calgary,Calgary,Canada

(3) Imelda General Hospital,Dr,Bonheiden,Belgium

(4) Charles University,Prague,Czech Republic

(5) AZ Delta Roeselare-Menen,Dept of Gastroenterology,Menen,Belgium

(6) Hepato-Gastroenterologie HK, s.r.o.,Hradec Králové,Czech Republic

(7) Bezmialem Vakif University,Gastroenterology,İstanbul,Turkey

(8) Medical University of Vienna,Vienna,Austria

(9) Presidio Columbus, Fondazione Policlinico Gemelli Università Cattolica,Rome,Italy

(10) Service de Gastroentérologie et Nutrition Clinique,Nice,France

(11) Oxford University Hospitals,Oxford,United Kingdom

(12) Istituto Clinico Humanitas,Millan,Italy

(13) University of California,San Diego,United States of America

(14) University of Leuven,Leuven,Belgium

(15) University of California,Los Angeles,United States of America

(16) University Hospital Schleswig-Holstein,UKSH,Kiel,Germany

(17) AbbVie Inc.,North Chicago,United States of America

(18) Academic Medical Center,Amsterdam,Netherlands



This item was part of UEG Week 2017

This item can be cited as: United European Gastroenterology Journal 2017; 5 (Supplement 1)